2021 Harvard Update in Clinical Cardiology

Wednesday, October 13, 2021
Introduction

• Key Points in Evaluation and Medical Management of Coronary Artery Disease
• Pulmonary Embolism: Pathophysiology and Management Updates
• The Role of the Cardiologists in Diabetes Management
• Updates to Evaluate and Treat Adult Congenital Heart Disease
• Mitral Regurgitation: Timing of Intervention and choice between Surgery and Percutaneous Therapy
• Advances in Medical Treatment of Systolic Heart Failure
• Advanced Heart Failure: Acute and Chronic Therapy
• Heart Failure with Preserved Ejection Fraction (HFpEF): 2021
• What’s New in Cardiac Markers

Thursday, October 14, 2021
Introduction

• Incorporating Advances in Electrical Therapy in Heart Failure for Improved Patient Outcomes
• Atrial Fibrillation: Pharmacologic and Nonpharmacologic Therapy
• Stroke Prevention in Atrial Fibrillation
• Supraventricular Tachycardia
• Dual Antiplatelet Therapy in Cardiovascular Disease
• Aortic Stenosis: Timing of Intervention and Choice Between Surgery and Percutaneous Therapy
• Thoracic Aortic Disease: Optimal Imaging and Management
• Hypertrophic Cardiomyopathy in 2021: Latest Concepts
• Acute Coronary Syndromes- STEMI and NSTEMI Latest Data

Friday, October 15, 2021

• Cardiovascular Care of Aging Athletes: Progress & Future Challenges
• How Exercise Protects the Heart
• Cardio-Oncology 2021
• Cardiovascular Disease and Pregnancy
• Coronary Disease: Medicate/Dilate/Operate
• COVID and Cardiovascular Disease
• Complex Coronary Artery Disease in the Cath Lab
• Dyslipidemia: Latest Concepts
• Cardiac Critical Care
• Closing Remarks